-transparent.png){kind=logo}
OBJECTIVE To demonstrate the association between tetracycline treatment and pseudotumor cerebri (PTC). METHODS Consecutive patients from two neuro-ophthalmic referral centers, who developed PTC syndrome post-treatment with tetracycline, were enrolled and followed for a minimum of 2 years after cessation of tetracycline. RESULTS A total of 243 consecutive patients were diagnosed with PTC; 18 had concurrent history of tetracycline treatment; a third experienced a limited course of illness with no relapses; 12 had a variable course with a prolonged relapsing illness. Mean duration of tetracycline treatment prior to diagnosis was 2.73 months. CONCLUSIONS Tetracycline, and especially minocycline, is currently considered a cause or a precipitating factor for PTC. Although there is little information on the natural course of tetracycline induced PTC, the present cases demonstrate that drug withdrawal is curative only in some patients.
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
April 1974,
Kinderarztliche Praxis,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
April 2023,
Advances in therapy,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
May 2007,
Journal of the American Academy of Audiology,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
January 1990,
Bulletin de la Societe belge d'ophtalmologie,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
February 1989,
American journal of ophthalmology,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
January 2002,
Japanese journal of ophthalmology,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
January 1973,
Deutsche medizinische Wochenschrift (1946),
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
December 1988,
Journal of periodontology,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
January 2003,
Clinical neuropharmacology,
A Kesler, and
Y Goldhammer, and
A Hadayer, and
P Pianka
March 2009,
Southern medical journal,
